Donna Hewitt

446 citations
12 papers · 351 indexed · h-index 5

Impact in

Papers in

    • Chronic Lymphocytic Leukemia Research 5
    • Bioactive Compounds and Antitumor Agents 1

Donna Hewitt

10 papers receiving 346 citations

Peers

Donna Hewitt
Comparison fields: 5 of 69
  • Reproductive Medicine 43
  • Cancer Research 63
  • Toxicology 14
  • Genetics 40
  • Oncology 94
Replace Bibo Yuan with:
Bibo Yuan China
Xupeng Yue China
Emanuela Fecarotta Italy
Pamela Younes United States
Payman Hanifi‐Moghaddam Netherlands
Kristin Padavic United States
Yoshitaka Kikukawa Japan
Mark Edelstein United States
Ruixiu Zhang China
Xiao Lv China
Donna Hewitt relative to Bibo Yuan China Bibo Yuan's profile →
Citations per field
00.5×
Bibo Yuan · 1×
Citations per year

Countries citing papers authored by Donna Hewitt

Since Specialization
Citations

This map shows the geographic impact of Donna Hewitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Hewitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Hewitt more than expected).

Fields of papers citing papers by Donna Hewitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Hewitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Hewitt. The network helps show where Donna Hewitt may publish in the future.

Co-authors

The 25 scholars most cited alongside Donna Hewitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Donna Hewitt Line = papers co-authored together Donna Hewitt links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 20240
2 202017
3 20204
4 20180
5 20174
6 20084
7 200627
8 200516
9 20052
10 2004156
11 1995119
12
Cancer morbidity in national-origin subgroups of the Ontario population.
19722

About Donna Hewitt

Donna Hewitt is a scholar working on Genetics, Toxicology, Geriatrics and Gerontology, Physiology and Hepatology, having authored 12 papers that have together received 351 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (3 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Bioactive Compounds and Antitumor Agents (1 paper), Autophagy in Disease and Therapy (1 paper), Global Cancer Incidence and Screening (1 paper) and Childhood Cancer Survivors' Quality of Life (1 paper). The work is most often cited by research in Reproductive Medicine (43 citations), Cancer Research (63 citations), Toxicology (14 citations), Genetics (40 citations) and Oncology (94 citations). Donna Hewitt has collaborated with scholars based in Canada, United Kingdom and United States. Frequent co-authors include Chris Boshoff, C. W. Perrett, Stephen Henderson, JA Ledermann, C. A. Chadwick, Gary Owen, B. I. Lord, C.S. Potten, Asher Begleiter and Andrew W. Maksymiuk. Their work appears in journals such as Blood, Cancers, British Journal of Cancer, Oral Oncology and European Journal of Preventive Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026